Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Ear Health

The Ear Health team's vision is all children start primary school with good hearing.

The Ear Health team's mission is to understand the causes of childhood hearing loss, including otitis media or OM (a disease of the middle ear), identify the extent of the problem and design and evaluate interventions to reduce the burden of the disease and inform policy.

We align our work with the team’s pillars: engagement, research, capacity building, service delivery, health promotion, and knowledge translation.

Our target group is all children, with a particular focus on Aboriginal children living in the Perth metropolitan area.

Our Ear Health team is a multidisciplinary group involved in epidemiological studies, qualitative research, data linkage, pathogenesis and clinical trials. An integral linkage for our team is the Aboriginal Community Advisory Group which guides the team in working in a culturally safe manner and provides direction to ensure the program is relevant and appropriate for their communities.   

Our key research projects focus on

  • Delivering the Djaalinj Waakinj Aboriginal ear health program which is examining the prevalence of OM and hearing loss in Aboriginal children living in Perth
  • Conducting clinical trials of interventions to improve the treatment of OM in children established by our team at Perth Children’s Hospital
  • Examining the prevalence of OM and its impact on later child development in collaboration with the Raine Study cohort.
  • Maintaining and updating a suite of Cochrane systematic reviews examining the most effective treatments for chronic suppurative otitis media. View the full Cochrane Special Collection here.
  • Developing new telehealth approaches to improve access to ear and hearing healthcare.
  • Developing guidelines for the treatment and management of OM in Aboriginal and Torres Strait Islander populations, available here.
  • Implementing the WA Child Ear Health Strategy.
  • Collaborating with the WA Country Health Service, Bega Garnbirringu Health Service on innovative pilot projects involving ear health screening when children attend for routine immunisations or child health checks.
  • Collaborating with the Papua New Guinea Institute of Medical to discover the key otopathogens causing otitis media in the Eastern Highlands, and the prevalence of ear disease in children <15 years in the region.  

We also work closely with other teams including the Bacterial Respiratory Infectious Disease Group (BRIDG) and Vaccine Trials Group.

Team Highlights

  • Expanded the Djaalinj Waakinj (Listening and Hearing) Ear Portal, to include more than 300 families with young Aboriginal children living in urban areas. The team published initial findings showing that over 50% of Aboriginal children in the study had ear disease by 6 months of age.
  • Established the Djaalinj Waakinj Centre for Ear and Hearing Health
  • Launched the 2020 Otitis Media Guidelines in partnership with the National Health and Medical Research Council (NHMRC) Centre for Research Excellence for Ear and Hearing Health, available online or as the downloadable “Otitis Media Guidelines” mobile application (OMApp).
  • Partnering with Perth Children’s Hospital to implement the Ear Portal telehealth clinical research pathway to reduce waiting times.
  • Implementation of the WA Child Ear Health Strategy. This state-wide, whole of Government approach to combat OM in Aboriginal children, led by The Kids researchers with WA Country Health and Child and Adolescent Health Services, Aboriginal Health Council of WA and WA Primary Healthy Alliance.
  • Awarding of an NHMRC Targeted Call for Research grant led by A/Prof Chris Brennan-Jones and A/Prof Val Swift to examine the prevalence of otitis media in Aboriginal children living within Western Australia.
  • Host team for students completing international internships in ear health research as part of the Princeton University Global Health Certificate.
  • Members of the WHO World Hearing Forum supporting global efforts to advocate for better ear health and safe listening environments.

Team leader

Team members (25)

Aboriginal Co-Director, Djaalinj Waakinj Centre for Ear and Hearing Health; Aboriginal Cultural Guidance Advisor

Program Manager, Ear Health

Karina Tao
Karina Tao

B.SpLPath&Aud, MClincAud, PhD

Clinical Research Audiologist

Clinical Research Officer/PhD student

Research Nurse & PhD student

Honorary Emeritus Fellow

Peter Richmond
Peter Richmond

MBBS MRCP(UK) FRACP

Head, Vaccine Trials Group

Dr Robyn Choi
Dr Robyn Choi

BSc MClinAud PhD MAudA AFHEA

Honorary Research Associate

Tanisha Cayley
Tanisha Cayley

BBiomed (Hons)

Clinical Research Audiologist

Aboriginal Research Assistant

Aboriginal Researcher

Rosemary Walley

Rosemary Walley

Aboriginal Researcher

Jess Daw

Jess Daw

Research Assistant

Ann Barblett

Ann Barblett

Volunteer

Lydia Timms

Lydia Timms

Honorary Research Associate

June Doyle

June Doyle

Honourary Research Associate

Babatunde Oremulé

Babatunde Oremulé

Honourary Research Associate

Celestine Aho

Celestine Aho

Honorary Research Associate

Glenys Yarran

Glenys Yarran

Honorary Elder Researcher

Doreen Nelson

Doreen Nelson

Honorary Elder Researcher

Dot Getta

Dot Getta

Honorary Elder Researcher

Helen Kickett

Helen Kickett

Honorary Elder Researcher

Stephanie Bray

Stephanie Bray

Aboriginal Research Assistant

Edna Ninyette

Edna Ninyette

Aboriginal Research Assistant

Ear Health projects

Show more projects

Featured projects

Goroka Otitis Media Study: Prevalence and associated risk factors of otitis media in children attending urban clinics in Goroka, Eastern Highlands Province of Papua New Guinea

Otitis media (OM, middle ear infections) and the consequent hearing loss are major concerns for Aboriginal people and OM can seriously impact on children’s learning potential which in turn will impact on life as an adult.

Healthy Ears Clinical Trial: A telehealth-facilitated randomised-controlled trial utilising a health promotion intervention to resolve otitis media with effusion for children won specialist Ear, Nose and Throat (ENT) waiting lists

A telehealth-facilitated randomised-controlled trial utilising a health promotion intervention to resolve otitis media with effusion for children won specialist Ear, Nose and Throat (ENT) waiting lists

Paediatric post-grommets surgery review: Audiology-led clinic

Otitis media has a high prevalence in childhood, and grommet insertion is the most common surgical treatment for OM. The public health system in Australia faces considerable strains, including high demand for Ear, Nose and Throat specialists. Extending the scope of practice for audiologists to manage post-operative care for children receiving grommets has the potential to alleviate this burden.

Risk of otitis media in offspring following maternal prenatal stress exposure

There is limited but consistent evidence that suggests prenatal factors, including maternal stress, may contribute to susceptibility for otitis media. We aimed to determine the effect of multiple life stress events during pregnancy on risk of acute and recurrent otitis media in offspring at three and five years of age. 

Geographical migration and fitness dynamics of Streptococcus pneumoniae

Streptococcus pneumoniae is a leading cause of pneumonia and meningitis worldwide. Many different serotypes co-circulate endemically in any one location. The extent and mechanisms of spread and vaccine-driven changes in fitness and antimicrobial resistance remain largely unquantified.

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

In Australian remote communities, First Nations children with otitis media (OM)-related hearing loss are disproportionately at risk of developmental delay and poor school performance, compared to those with normal hearing. Our objective was to compare OM-related hearing loss in children randomised to one of 2 pneumococcal conjugate vaccine (PCV) formulations.

Show all